Efficacy of ondansetron in the treatment of generalized anxiety disorder.
Freeman
A M
AM
Westphal
J R
JR
Norris
G T
GT
Roggero
B A
BA
Webb
P B
PB
Freeman
K L
KL
Rush
J A
JA
Hearne
E M
EM
Evoniuk
G
G
D000328:Adult; D014151:Anti-Anxiety Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D003975:Diazepam / Q000009:adverse effects / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017294:Ondansetron / Q000009:adverse effects / Q000627:therapeutic use*; D010865:Pilot Projects; D011569:Psychiatric Status Rating Scales; D012702:Serotonin Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D014151:Anti-Anxiety Agents; D012702:Serotonin Antagonists; D017294:Ondansetron; D003975:Diazepam